Filing Details
- Accession Number:
- 0001415889-22-002508
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-04 12:28:17
- Reporting Period:
- 2022-03-02
- Accepted Time:
- 2022-03-04 12:28:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1748208 | Joshua Foukas | 3838 West Parkway Blvd. Salt Lake City UT 84120 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-03-02 | 3,303 | $89.93 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Weighted average price $89.9283. Price range in multiple transactions was $89.85 to $90.115 inclusively.
Billionaire Hedge Funds
